Your account is not claimed yet. You can sign up with ORCID to claim your account.

Yotam Bar-On

Years Active: 2020-2023
Publications (10 Years): 5

Technion Israel Institute of Technology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Technion Israel Institute of Technology

Israel

PI :: Immunology

Publications

Inbal Kol, Ahmed Rishiq, Mevaseret Cohen, Shira Kahlon, Ophir Pick, Liat Dassa, Natan Stein, Yotam Bar-On, Dana G Wolf, Einat Seidel, Ofer Mandelboim
CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. The Journal of cell biology 222 (9) (2023)
Inbal Kol, Ahmed Rishiq, Mevaseret Cohen, Shira Kahlon, Ophir Pick, Liat Dassa, Natan Stein, Yotam Bar-On, Dana G Wolf, Einat Seidel, Ofer Mandelboim
CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. The Journal of cell biology 222 (9) (2023)
Inbal Kol, Ahmed Rishiq, Mevaseret Cohen, Shira Kahlon, Ophir Pick, Liat Dassa, Natan Stein, Yotam Bar-On, Dana G Wolf, Einat Seidel, Ofer Mandelboim
CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. The Journal of cell biology 222 (9) (2023)
Dina Khateeb, Tslil Gabrieli, Bar Sofer, Adi Hattar, Sapir Cordela, Abigael Chaouat, Ilia Spivak, Izabella Lejbkowicz, Ronit Almog, Michal Mandelboim, Yotam Bar-On
SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection. PLoS pathogens 18 (1) (2022)
Magnus A G Hoffmann, Yotam Bar-On, Zhi Yang, Harry B Gristick, Priyanthi N P Gnanapragasam, Jost Vielmetter, Michel C Nussenzweig, Pamela J Bjorkman
Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells. Proceedings of the National Academy of Sciences of the United States of America 117 (31) (2020)

Yotam Bar-On.css-eqlu8i{font-size:small;padding-left:4px;}